KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Interest Coverage Ratio (2016 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Interest Coverage Ratio for 18 consecutive years, with 22.76 as the latest value for Q1 2026.

  • For Q1 2026, Interest Coverage Ratio rose 36.34% year-over-year to 22.76; the TTM value through Mar 2026 reached 19.23, up 30.99%, while the annual FY2025 figure was 4.62, 83.48% up from the prior year.
  • Interest Coverage Ratio hit 22.76 in Q1 2026 for Ionis Pharmaceuticals, up from 44.42 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 33.99 in Q2 2025 and bottomed at 120.17 in Q4 2022.
  • Average Interest Coverage Ratio over 5 years is 34.16, with a median of 35.73 recorded in 2024.
  • Year-over-year, Interest Coverage Ratio tumbled 1868.73% in 2024 and then skyrocketed 330.89% in 2025.
  • Ionis Pharmaceuticals' Interest Coverage Ratio stood at 120.17 in 2022, then surged by 98.88% to 1.34 in 2023, then crashed by 1868.73% to 26.44 in 2024, then crashed by 67.99% to 44.42 in 2025, then surged by 48.77% to 22.76 in 2026.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 22.76, 44.42, and 38.03 for Q1 2026, Q4 2025, and Q3 2025 respectively.